VAERS reports by lot

GSK DTaP/Tdap lot 7745R: VAERS reports

21 VAERS reports list lot 7745R as a GSK DTaP/Tdap vaccine, received between 2023-08-24 and 2024-10-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
5%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction531%
General / Systemic (non-local)425%
Neurological212%
Dermatological (non-injection-site)212%
Thrombotic / Hematological16%
Allergic / Anaphylactic16%
Musculoskeletal16%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
California2
Michigan2
Alabama2
Massachusetts1
North Carolina1
Illinois1
Iowa1
Tennessee1
New Jersey1
Kentucky1
Florida1

Reports by month received

2023-081
2023-091
2023-101
2023-122
2024-011
2024-031
2024-043
2024-052
2024-062
2024-071
2024-082
2024-104

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.